Rapid Sepsis Triage Using Label-Free Autofluorescence

Spectrosense is developing a portable, near-patient platform that detects the body’s immune response to infection in seconds, enabling earlier and more informed clinical decisions.

What is the Problem?

Sepsis is time-critical and underdiagnosed

Sepsis progresses rapidly, yet current diagnostics often take hours to days, forcing clinicians to act without clear biological insight.

Clinical scores and biomarkers provide indirect signals, while molecular diagnostics require time, infrastructure, and consumables.

Each hour of delayed intervention increases mortality risk and contributes to unnecessary antibiotic use.

Current tools are limited

Delays cost lives and resources

The Solution

A new class of diagnostic signal

Spectrosense measures metabolic autofluorescence from immune cells to directly assess the body’s response to infection.

Results in seconds

The system generates an infection-likelihood score in near real-time at the point of care.

Portable, reagent-free, and built for emergency and acute care environments.